By separately incorporating IL-6 and TNF-α, ROC curve analysis showed that TNF-α levels; 6.620 ng/mL could predict adverse functional outcomes in adults with MMD, with a sensitivity of 64.1%, a specificity of 56.4%, and an area under the curve is 0.609. This evidence concerns the gene TNF and multiminicore myopathy.